Chargement en cours...
Adherence to lenalidomide in older adults with newly-diagnosed multiple myeloma
INTRODUCTION: One of the most common orally administered anti-myeloma agent, lenalidomide, has significantly improved outcomes in multiple myeloma, including in older patients. However, despite its utilization and cost, the rates and factors related to adherence to lenalidomide in older adults with...
Enregistré dans:
| Publié dans: | Clin Lymphoma Myeloma Leuk |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7564009/ https://ncbi.nlm.nih.gov/pubmed/31843543 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2019.09.618 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|